MR imaging and proton MR spectroscopy in A-to-G substitution at nucleotide position 3243 of leucine transfer RNA

American Journal of Neuroradiology

Volumn 19, Issue 2, 1998, Pages 231-234

  Bowen, James ^a,c   Richards, Todd ^b   Maravilla, Kenneth ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; DNA; LACTIC ACID; LEUCINE; N ACETYLASPARTIC ACID; NUCLEOTIDE; TRANSFER RNA;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEARING IMPAIRMENT; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; AMINO ACID SUBSTITUTION; ASPARTIC ACID; BASAL GANGLIA; BASE SEQUENCE; BRAIN; CEREBRAL CORTEX; CHOLINE; CREATINE; DEAFNESS; DIABETES MELLITUS, TYPE 1; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; LACTIC ACID; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; MITOCHONDRIAL ENCEPHALOMYOPATHIES; RNA, TRANSFER, LEU;

EID: 0032471512     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. DiMauro S, Bonilla E, Lombes A, Shanske S, Minetti C, Moraes C. Mitochondrial encephalomyopathies. Neurol Clin 1990;8:483-506
2. Bottomley P. Selective volume method for performing localized NMR spectroscopy. US patent 4 480 228.1984
3. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994;330:962-968
4. Hammans S, Sweeney M, Hanna M, Brockington M, Morgan-Hughes J, Harding A. The mitochondrial DNA transfer RNALeu(UUR) A→G (3243) mutation: a clinical and genetic study. Brain 1995;118:721-734
5. Moraes C, Ciacci F, Silvestri G, et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord 1993;3:43-50
6. Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-653
7. Kobayashi Y, Momoi M, Tominaga K, et al. A point mutation in the mitochondrial tRNALeu(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun 1990;173:816-822
8. Folgero T, Torbergsen T, Oian P. The 3243 MELAS mutation in a pedigree with MERRF. Eur Neurol 1995;35:168-171
9. Sasagasako N, Shida N, Yoshimura T, Kobayashi T, Goto I. A family with MELAS whose main manifestations are maternally-transmitted deafness and diabetes mellitus. Rinsho Shiol 1993;33: 657-659
10. Crimmins D, Morris J, Walker G, et al. Mitochondrial encephalomyopathy: variable clinical expression within a single kindred. J Neurol Neurosurg Pychiatry 1993;56:900-905
11. Gerbitz K, van den Ouweland J, Maassen J, Jaksch M. Mitochondrial diabetes mellitus: a review. Biocim Biophys Acta 1995;1271: 253-260
12. Barrett T, Bundey S, Macleod A. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995;346:1458-1463
13. Castillo M, Kwock L, Green C. MELAS syndrome: imaging and . proton MR spectroscopic findings. AJNR Am J Neuroradiol 1995; 16:233-239
14. Barkovich A, Good W, Koch T, Berg B. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol 1993;14:1119-1137
15. Wray S, Provenzale J, Johns D, Thulborn K. MR of the brain in mitochondrial myopathy. AJNR Am J Neuroradiol 1995;16:1167-1173
16. Campos Y, Bautista J, Gutierrez-Rivas E, et al. Clinical heterogeneity in two pedigrees with the 3243 bp tRNALeu(UUR) mutation of mitochondrial DNA. Acta Neurol Scand 1995;91:62-65
17. Hara K, Yamamoto M, Anegawa T, Sakuta R, Nakamura M. Mitochondrial encephalomyopathy associated with parkinsonism and a point mutation in the mitochondrial tRNA(Leu)(UUR) gene. Rinsho Shinkeigaku 1994;34:361-365
18. Bresolin N, Martinelli P, Barbiroli B, et al. Muscle mitochondrial DNA deletion and 31P-NMR spectroscopy alteration in a migraine patient. J Neurol Sci 1991;104:182-189
19. Arus C, Chang Y, Barany M. Proton nuclear magnetic resonance spectra of excised rat brain: assignment of resonances. Physiol Chem Phys Med NMR 1985;17:23-33
20. Pettegrew JW, Kopp JS, et al. 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations. J Neuropathol Exp Neurol 1987;46:419-430
21. Tunggal B, Hofmann K, Stoffel W. In vivo 13C nuclear magnetic resonance investigations of choline metabolism in rabbit brain. Magn Reson Med 1990;13:90-102
22. Bruhn H, Frahm J, Gyngell M, Merboldt K, Hanicke W, Sauter R. Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy. Magn Reson Med 1989; 9:126-131
23. Birken DL, Oldendorf W. N-acetyl-L-aspartic acid: a literature renew of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989;13:23-31
24. Arnold D, Matthews P, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med 1990;14:154-159
25. vanHecke P, Marchal G, Johannik K, et al. Human brain proton localized NMR spectroscopy in multiple sclerosis. Magn Reson Med 1991;18:199-206